Our cancer centers need Congress to pass robust NIH budget
By Drs. Michael B. Kastan, Norman E. Sharpless and Boris Pasche
When members of Congress return to Washington at the end of this month, we are hopeful they will recognize there is a mutual and national benefit to working together to pass an omnibus package for Fiscal Year 2017 that includes robust investments in the National Institutes of Health and National Cancer Institute.
We are quite fortunate in North Carolina to have three NCI-designated comprehensive cancer centers, a distinction achieved by conducting basic, clinical and population-scale cancer research. As the directors of those centers, we know firsthand that strong and sustained investments in the NIH and NCI drive the meaningful progress in cancer research and discovery that enables our caregivers to provide better and more effective cancer care.
Our three cancer centers have a history of making groundbreaking discoveries that improve our ability to prevent, diagnose and more effectively treat cancer. . . Read more at The Heard Sun.